Institut Pere Mata S.A.
- Address
- Carretera De l'Institut Pere Mata Sn, 43206 Reus, Spain
Institut Pere Mata S.A. - Psychotic Disorders and Schizophrenia Research
Institut Pere Mata S.A. is a specialized psychiatric research institution conducting innovative studies in psychotic disorders, with particular emphasis on first-episode psychosis and schizophrenia spectrum disorders. The center demonstrates expertise in integrating cutting-edge multi-omics technologies and systems biology approaches to advance precision psychiatry and optimize treatment strategies for patients experiencing their initial psychotic episodes.
- Biomarker discovery using multi-omics techniques to predict antipsychotic treatment response
- Comparative effectiveness research of antipsychotic medications (aripiprazole and paliperidone) in first-episode psychosis
- Long-term treatment outcomes and medication adherence assessment in schizophrenia spectrum disorders
The institute's research program focuses on personalized treatment approaches in early psychosis, utilizing comprehensive outcome measures including the PANSS and CGI-S scales to evaluate both short-term efficacy and long-term effectiveness. Their multidisciplinary methodology combines biological markers with clinical assessment to identify predictors of therapeutic response, ultimately aiming to improve treatment selection and patient outcomes during the critical early phases of schizophrenia spectrum illnesses.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institut Pere Mata S.A.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Aripiprazole vs. Paliperidone/Risperidone in First Episode Psychosis Using Multi-omics Data | Consorcio Centro De Investigacion Biomedica En Red | Phase III | Recruiting | Dec 2024 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aripiprazole | 1 | Unknown | 2024-12-16 | 2024-12-16 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.